Cargando…

High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia

BACKGROUND: Cryptococcal disease is estimated to be responsible for significant mortality in Sub-Saharan Africa; however, only scarce epidemiology data exists. We sought to evaluate the prevalence of and risk factors for cryptococcal antigenemia in Ethiopia. METHODS: Consecutive adult HIV-infected p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alemu, Abere Shiferaw, Kempker, Russell R., Tenna, Admasu, Smitson, Christopher, Berhe, Nega, Fekade, Daniel, Blumberg, Henry M., Aseffa, Abraham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587601/ https://www.ncbi.nlm.nih.gov/pubmed/23469276 http://dx.doi.org/10.1371/journal.pone.0058377

Ejemplares similares

No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia
por: Smitson, Christopher C., et al.
Publicado: (2014)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia
por: Derbie, Awoke, et al.
Publicado: (2018)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
por: Negash, Markos, et al.
Publicado: (2020)

Effectiveness of a multimodal hand hygiene campaign and obstacles to success in Addis Ababa, Ethiopia
por: Schmitz, Karen, et al.
Publicado: (2014)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence
por: Oladele, Rita O., et al.
Publicado: (2016)

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
por: Smith, Rachel M., et al.
Publicado: (2013)

Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia
por: Geda, Nuguse, et al.
Publicado: (2019)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic
por: Reepalu, Anton, et al.
Publicado: (2015)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia
por: Ganiem, Ahmad Rizal, et al.
Publicado: (2014)

Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau
por: Thomsen, Ditte, et al.
Publicado: (2018)

Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia
por: Hlupeni, Admire, et al.
Publicado: (2018)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
por: Xu, Xiao-Lei, et al.
Publicado: (2020)

The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort()
por: Patel, Sheel, et al.
Publicado: (2013)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Prevalence of Cryptococcal Antigenemia and Associated Factors among HIV/AIDS Patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia
por: Jemal, Mohabaw, et al.
Publicado: (2021)

Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda
por: Butler, Elissa K., et al.
Publicado: (2012)

Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
por: Huang, Sung-Hsi, et al.
Publicado: (2021)

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
por: Deiss, Robert, et al.
Publicado: (2021)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2023)

Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania
por: Magambo, Kinanga A, et al.
Publicado: (2014)

Efficacy of artemether–lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2015)

Re-evaluation of microscopy confirmed Plasmodium falciparum and Plasmodium vivax malaria by nested PCR detection in southern Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2014)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
por: Montgomery, Martha P., et al.
Publicado: (2017)

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi
por: Chisale, Master R. O., et al.
Publicado: (2023)

Cryptococcal antigenemia and associated risk factors among ART‐naïve and ART‐experienced HIV‐infected peoples at selected health institutions of Mekelle, Northern Ethiopia
por: Hailu, Kibra, et al.
Publicado: (2018)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa
por: Larson, Bruce A., et al.
Publicado: (2016)

Comment on “Cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)”
por: Joob, Beuy, et al.
Publicado: (2012)

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality
por: Letang, Emilio, et al.
Publicado: (2015)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam
por: Dat, Vu Quoc, et al.
Publicado: (2021)

Cost-effectiveness of WHO-Recommended Algorithms for TB Case Finding at Ethiopian HIV Clinics
por: Adelman, Max W, et al.
Publicado: (2017)

Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia
por: Fiseha, Temesgen, et al.
Publicado: (2019)

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm(3)
por: Wykowski, James, et al.
Publicado: (2020)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia
por: Berhe, Gebretsadik, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vkhe9rbfk346dt8sba48lstt8g